PART I . Our Company We are a global leader in biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. MIDD is an approach that utilizes biological and statistical models derived from preclinical, clinical, and evidence data to inform decision-making in drug research and development, and commercialization. Biosimulation is a critical component of MIDD that uses computer-aided mathematical si...
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001827090-26-000011 | EDGAR | 70K words |
| 2025-02-26 | 2024-12-31 | 0001827090-25-000014 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001827090-24-000006 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0001558370-23-002605 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001558370-22-002608 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001558370-21-002979 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-30 | 0001827090-26-000028 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001827090-25-000048 | EDGAR | 26K words |
| 2025-08-06 | 2025-06-30 | 0001827090-25-000036 | EDGAR | — |
| 2025-05-05 | 2025-03-31 | 0001827090-25-000028 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001827090-24-000037 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001827090-24-000029 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001827090-24-000013 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001827090-23-000021 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001827090-23-000010 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0001558370-23-008541 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0001558370-22-016642 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001558370-22-012907 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-07 | 0001104659-26-092730 | EDGAR | — |
| 2026-08-04 | 0001827090-26-000026 | EDGAR | — |
| 2026-08-04 | 0001104659-26-090050 | EDGAR | — |
| 2026-03-31 | 0001104659-26-037798 | EDGAR | 1K words |
| 2026-02-26 | 0001827090-26-000008 | EDGAR | — |
| 2025-12-11 | 0001104659-25-120096 | EDGAR | — |
| 2025-11-06 | 0001827090-25-000046 | EDGAR | — |
| 2025-10-16 | 0001104659-25-100106 | EDGAR | — |
| 2025-08-06 | 0001827090-25-000034 | EDGAR | — |
| 2025-05-22 | 0001104659-25-052027 | EDGAR | — |
92 total filings indexed. 64 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001827090 |
| Ticker | CERT |
| Exchange | Nasdaq |
| SIC | 7372: Services-Prepackaged Software |
| Incorporated | DE |
| Website | https://www.certara.com |
| Listed | 2020-12-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CERT (~200 tokens, structured JSON with cryptographic provenance)